NCT00945893View on ClinicalTrials.gov

A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
BIOLOGICAL

MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]

0.5 mL; (intranasal sprayer)

OTHER

Placebo

(intranasal sprayers containing 0.5 mL of sucrose-phosphate buffer)

Trial Locations (5)

30060

Covance Daytona Beach, Daytona Beach

33126

Pharmax Research Clinic, Miami

33143

Miami Research Associates, South Miami

37203

Clinical Research Associates, Inc., Nashville

64114

Center for Pharmaceutical Research, Kansas City

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

MedImmune LLC

INDUSTRY